Evaluation of Serological Tests for Detection of Antibodies against Lumpy Skin Disease Virus

Lumpy skin disease (LSD) is an emerging, transboundary viral pox disease affecting cattle of all ages and breeds. The serological assay for monitoring immunity following vaccination is a virus neutralization test (VNT/OIE) that determines the neutralization index (NI). The first validated enzyme-linked immunosorbent assay (ELISA; IDVet) has become commercially available, facilitating large-scale serosurveillance for LSD. Although the VNT is labor intensive and time consuming, it is still the recommended test by the OIE. ABSTRACT Lumpy skin disease (LSD) is an emerging, transboundary viral pox disease affecting cattle of all ages and breeds. The serological assay for monitoring immunity following vaccination is a virus neutralization test (VNT/OIE) that determines the neutralization index (NI). The first validated enzyme-linked immunosorbent assay (ELISA; IDVet) has become commercially available, facilitating large-scale serosurveillance for LSD. Although the VNT is labor intensive and time consuming, it is still the recommended test by the OIE. Thus, in this study, we modified the virus neutralization test by employing Madin-Darby bovine kidney (MDBK) cells. The qualitative results obtained with the modified method were compared to the qualitative results obtained by VNT/OIE and ELISA. We used blood sera received within a surveillance program for LSD in 2018. In total, 291 serum samples were tested using VNT/MDBK and ELISA. Of 291 samples, 80 samples were tested by VNT/OIE and used for comparison of the performances between VNT/MDBK and VNT/OIE. The compatibility of results obtained by VNT/MDBK and VNT/OIE resulted in a kappa index of 0.9 with overall proportion agreement of 0.96. Agreement between VNT/MDBK and VNT/OIE was achieved in 56 positive and 21 negative samples. The compatibility of results obtained by ELISA and VNT/MDBK were compared on 291 samples in total and resulted in a kappa index 0.834 with overall proportion agreement of 0.955. Agreement between ELISA and VNT/MDBK was achieved in 238 positive and 40 negative samples. The results obtained demonstrated a strong correlation between VNT/MDBK and the other two methods, indicating the suitability of VNT/MDBK for the detection of the LSD virus-specific neutralizing antibodies.

[1]  O. Nir,et al.  Spread of lumpy skin disease in Israeli dairy herds , 1995, Veterinary Record.

[2]  R. Grabherr,et al.  An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species , 2019, Scientific Reports.

[3]  D. Lupulović,et al.  Detection of antibodies against Lumpy skin disease virus by Virus neutralization test and ELISA methods , 2019, Acta Veterinaria.

[4]  J. Coetzer,et al.  Mechanical transmission of lumpy skin disease virus by Rhipicephalus appendiculatus male ticks , 2012, Epidemiology and Infection.

[5]  A. I. Khalafalla,et al.  Lumpy skin disease: observations on the recent outbreaks of the disease in the Sudan. , 1993, Revue d'elevage et de medecine veterinaire des pays tropicaux.

[6]  B. Hoffmann,et al.  Humoral immune response to repeated lumpy skin disease virus vaccination and performance of serological tests , 2019, BMC Veterinary Research.

[7]  D. Wallace,et al.  Transmission of lumpy skin disease virus: A short review. , 2019, Virus research.

[8]  H. Yılmaz.  Lumpy Skin Disease: Global and Turkish Perspectives , 2017 .

[9]  R. Kitching,et al.  Mechanical transmission of lumpy skin disease virus by Aedes aegypti (Diptera: Culicidae) , 2001, Epidemiology and Infection.

[10]  L. Babiuk,et al.  Review: Capripoxvirus Diseases: Current Status and Opportunities for Control , 2015, Transboundary and emerging diseases.

[11]  R. Kitching,et al.  Evaluation of an Ovine Testis Cell Line (OA3.Ts) for Propagation of Capripoxvirus Isolates and Development of an Immunostaining Technique for Viral Plaque Visualization , 2007, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[12]  M. Beer,et al.  Experimental lumpy skin disease virus infection of cattle: comparison of a field strain and a vaccine strain , 2019, Archives of Virology.

[13]  D. Calavas,et al.  Spread rate of lumpy skin disease in the Balkans, 2015–2016 , 2018, Transboundary and emerging diseases.

[14]  C. Saegerman,et al.  Risk of introduction of lumpy skin disease in France by the import of vectors in animal trucks , 2018, PloS one.

[15]  D. Wallace,et al.  Lumpy skin disease in southern Africa: a review of the disease and aspects of control. , 2001, Journal of the South African Veterinary Association.

[16]  J. Coetzer,et al.  Evidence of transstadial and mechanical transmission of lumpy skin disease virus by Amblyomma hebraeum ticks. , 2015, Transboundary and emerging diseases.

[17]  E. Palmer,et al.  Poxviridae , 2019, Electron Microscopy in Viral Diagnosis.

[18]  S. Babiuk,et al.  Detection of antibodies against capripoxviruses using an inactivated sheeppox virus ELISA. , 2009, Transboundary and emerging diseases.

[19]  N. Krešić,et al.  Detection of lumpy skin disease virus in skin lesions, blood, nasal swabs and milk following preventive vaccination. , 2018, Transboundary and emerging diseases.

[20]  Shefaa A. M. El-Mandrawy,et al.  Hematological, biochemical and oxidative stress studies of lumpy skin disease virus infection in cattle , 2018 .